©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2743-2749
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743
Table 2 Clinicopathologic findings of esophageal cancers detected in this study
| Size (mm), median (range) | 12.5 (5-60) |
| Depth1 | |
| Tis/T1a/T1b | 12/15/5 |
| Location | |
| Ce/Ut/Mt/Lt/Mt-Lt/Ae | 0/1/20/8/2/1 |
| Macroscopic type | |
| 0-IIc/0-IIc + IIa/0-I + IIb | 30/1/1 |
| Histopathological type | |
| SCC/ adenocarcinoma | 31/1 |
| Treatment2, endoscopic treatment/ surgery/chemoradiotherapy/ radiation/unknown | 28/1/3/1/1 |
| Lymph node metastasis | |
| Positive/negative | 1/31 |
| Distant metastasis | |
| Positive/negative | 0/32 |
- Citation: Sekiguchi M, Terauchi T, Kakugawa Y, Shimada N, Saito Y, Matsuda T. Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. World J Gastroenterol 2017; 23(15): 2743-2749
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2743.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2743